Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Axsome Thera (AXSM)

3.45 -0.025 (-0.72%)

05-18 16:00

Open:

3.45

Pre. Close:

3.475

High:

3.4752

Low:

3.4

Volume:

75,467

Market Cap:

89M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.485 - 3.503

3.503 - 3.517

Low:

3.36 - 3.378

3.378 - 3.393

Close:

3.423 - 3.452

3.452 - 3.476

Technical analysis  (as of: 2018-05-18 4:31:16 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 4.32     One year: 5.05

Support:

Support1: 2.93    Support2: 2.45

Resistance:

Resistance1: 3.70    Resistance2: 4.32

Pivot:

3.39

Moving Averages:

MA(5): 3.50     MA(20): 3.24

MA(100): 3.06     MA(250): 4.27

MACD:

MACD(12,26): 0.21     Signal(12,26,9): 0.21

%K %D:

%K(14,3): 70.69     %D(3): 77.89

RSI:

RSI(14): 66.99

52-Week:

High: 6.45  Low: 2.05  Change(%): -21.6

Average Vol(K):

3-Month: 19495  10-Days 13972

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AXSM has closed below upper band by 34.8%. Bollinger Bands are 61.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to AXSM's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-14T12:27:31-04:00
Oryzon Genomics commences mid-stage study of Alzheimer's candidate

2018-05-08T12:34:10-04:00
Axsome Therapeutics' (AXSM) CEO Herriot Tabuteau on Q1 2018 Results - Earnings Call Transcript

2018-04-30T14:11:43-04:00
Week 18 Breakout Forecast: Short-Term Picks To Give You An Edge

2018-04-29T08:00:00-04:00
3 Things In Biotech, April 28: Fighting Mental Disorders, And A New Strategy For Bacteria?

2018-04-26T12:40:08-04:00
Midday Gainers / Losers (04/26/2018)

2018-04-26T09:23:53-04:00
Premarket Gainers as of 9:05 am (04/26/2018)

2018-04-26T08:34:35-04:00
Axsome's late-stage study of AXS-05 in treatment-resistant depression to continue; shares up 13% premarket

2018-04-24T08:00:00-04:00
Your Daily Pharma Scoop: Roche's Ocrevus, Biogen Data, Biohaven Update

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

25.69

Shares Float (M)

24.97

% Held by Insiders

2.80

% Held by Institutions

27.00

Shares Short (K)

622

Shares Short Prior Month (K)

474

Stock Financials

EPS

-1.040

EPS Est. Current Year

-1.380

EPS Est. Next Year

-0.910

EPS Est. Next Quarter

-0.340

Forward EPS

-0.520

Book Value (p.s.)

6.890

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-78.5

Return on Equity (ttm)

-151.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.507

Qtrly Earnings Growth

Operating Cash Flow (M)

-26.47

Levered Free Cash Flow (M)

-13.47

atoplab.com

Valuation

P/E

-3.32

P/E Growth Ratio

-0.01

P/BV

0.50

P/S

P/CF

-3.35

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.